Researcher.Life Logo

Advanced Therapeutics : Impact Factor & More

eISSN: 2366-3987pISSN: 2366-3987

Key Metrics

CiteScore
7
Impact Factor
< 5
SJR
Q4Pharmacology
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Advanced Therapeutics

Advanced Therapeutics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher Wiley-Blackwell
Language English
Frequency Monthly
Article Processing ChargesUSD 3900
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2018
Publisher URLVisit website
Publication Details
View less

Planning to publish in Advanced Therapeutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Advanced Therapeutics

Therapeutic Targeting of MELK by Repurposed Drugs Netarsudil and Dutasteride Suppresses Triple‐Negative Breast Cancer Cell Progression: Evidence From Molecular Simulations and Functional Validations
  • 24 Oct 2025
  • Advanced Therapeutics
Selective Binding of Autoantibodies using Polymeric Gel for Management of Autoimmune Arthritis
  • 20 Oct 2025
  • Advanced Therapeutics
Structural Characterization and AI‐Enhanced Modeling of a Broadly Neutralizing Camelid Antibody Against SARS‐CoV‐2 Variants
  • 20 Oct 2025
  • Advanced Therapeutics
PVA‐co‐PAMPS Membranes with Selective Anticancer Activity and Metabolic Stimulation of Healthy Cells
  • 10 Oct 2025
  • Advanced Therapeutics
Calcium/Alginate Hydrogel with Hydroxytyrosol Improves Diabetic Wound Healing Through the Activation of Nuclear Factor Erythroid 2‐Related Factor 2 Signaling Pathway
  • 6 Oct 2025
  • Advanced Therapeutics
Gallium β‐Cyclodextrin Nanoparticles Containing both Gallium Protoporphyrin and Gallium Nitrate Exhibit Antimicrobial Activity against Nontuberculous Mycobacteria in Vitro and in Vivo
  • 5 Oct 2025
  • Advanced Therapeutics
Therapeutic Targeting of MELK by Repurposed Drugs Netarsudil and Dutasteride Suppresses Triple‐Negative Breast Cancer Cell Progression: Evidence From Molecular Simulations and Functional Validations
  • 24 Oct 2025
  • Advanced Therapeutics
Selective Binding of Autoantibodies using Polymeric Gel for Management of Autoimmune Arthritis
  • 20 Oct 2025
  • Advanced Therapeutics
Structural Characterization and AI‐Enhanced Modeling of a Broadly Neutralizing Camelid Antibody Against SARS‐CoV‐2 Variants
  • 20 Oct 2025
  • Advanced Therapeutics
PVA‐co‐PAMPS Membranes with Selective Anticancer Activity and Metabolic Stimulation of Healthy Cells
  • 10 Oct 2025
  • Advanced Therapeutics
Calcium/Alginate Hydrogel with Hydroxytyrosol Improves Diabetic Wound Healing Through the Activation of Nuclear Factor Erythroid 2‐Related Factor 2 Signaling Pathway
  • 6 Oct 2025
  • Advanced Therapeutics
Gallium β‐Cyclodextrin Nanoparticles Containing both Gallium Protoporphyrin and Gallium Nitrate Exhibit Antimicrobial Activity against Nontuberculous Mycobacteria in Vitro and in Vivo
  • 5 Oct 2025
  • Advanced Therapeutics

FAQs on Advanced Therapeutics